Jennifer E Dulle1, Patrice E Fort2. 1. Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA. 2. Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA. Electronic address: patricef@umich.edu.
Abstract
BACKGROUND: There is an abundance of evidence to support the association of damaging neuroinflammation and neurodegeneration across a multitude of diseases. One of the links between these pathological phenomena is the role of chaperone proteins as both neuroprotective and immune-regulatory agents. SCOPE OF REVIEW: Chaperone proteins are highly expressed at sites of neuroinflammation both in glial cells and in the injured neurons that initiate the immune response. For this reason, the use of chaperones as treatment for various diseases associated with neuroinflammation is a highly active area of investigation. This review explores the various ways that the small heat shock protein chaperones, α-crystallins, can affect glial cell function with a specific focus on their implication in the inflammatory response associated with neurodegenerative disorders, and their potential as therapeutic treatment. MAJOR CONCLUSIONS: Although the mechanisms are still under investigation, a clear link has now been established between alpha-crystallins and neuroinflammation, especially through their roles in microglial and macroglial cells. Interestingly, similar to inflammation in itself, crystallins can have a beneficial or detrimental impact on the CNS based on the context and duration of the condition. GENERAL SIGNIFICANCE: Overall this review points out the novel roles that chaperones such as alpha-crystallins can play outside of the classical protein folding pathways, and their potential in the development of new therapies for the treatment of neuroinflammatory/neurodegenerative diseases. This article is part of a Special Issue entitled Crystallin Biochemistry in Health and Disease.
BACKGROUND: There is an abundance of evidence to support the association of damaging neuroinflammation and neurodegeneration across a multitude of diseases. One of the links between these pathological phenomena is the role of chaperone proteins as both neuroprotective and immune-regulatory agents. SCOPE OF REVIEW: Chaperone proteins are highly expressed at sites of neuroinflammation both in glial cells and in the injured neurons that initiate the immune response. For this reason, the use of chaperones as treatment for various diseases associated with neuroinflammation is a highly active area of investigation. This review explores the various ways that the small heat shock protein chaperones, α-crystallins, can affect glial cell function with a specific focus on their implication in the inflammatory response associated with neurodegenerative disorders, and their potential as therapeutic treatment. MAJOR CONCLUSIONS: Although the mechanisms are still under investigation, a clear link has now been established between alpha-crystallins and neuroinflammation, especially through their roles in microglial and macroglial cells. Interestingly, similar to inflammation in itself, crystallins can have a beneficial or detrimental impact on the CNS based on the context and duration of the condition. GENERAL SIGNIFICANCE: Overall this review points out the novel roles that chaperones such as alpha-crystallins can play outside of the classical protein folding pathways, and their potential in the development of new therapies for the treatment of neuroinflammatory/neurodegenerative diseases. This article is part of a Special Issue entitled Crystallin Biochemistry in Health and Disease.
Authors: Jonathan B Rothbard; Michael P Kurnellas; Sara Brownell; Chris M Adams; Leon Su; Robert C Axtell; Rong Chen; C Garrison Fathman; William H Robinson; Lawrence Steinman Journal: J Biol Chem Date: 2012-02-03 Impact factor: 5.157
Authors: J M van Noort; A C van Sechel; J J Bajramovic; M el Ouagmiri; C H Polman; H Lassmann; R Ravid Journal: Nature Date: 1995-06-29 Impact factor: 49.962
Authors: Mehdi Mirzaei; Kanishka Pushpitha; Liting Deng; Nitin Chitranshi; Veer Gupta; Rashi Rajput; Abu Bakr Mangani; Yogita Dheer; Angela Godinez; Matthew J McKay; Karthik Kamath; Dana Pascovici; Jemma X Wu; Ghasem Hosseini Salekdeh; Tim Karl; Paul A Haynes; Stuart L Graham; Vivek K Gupta Journal: Mol Neurobiol Date: 2019-02-01 Impact factor: 5.590
Authors: Adrienne M Antonson; Marcus A Lawson; Megan P Caputo; Stephanie M Matt; Brian J Leyshon; Rodney W Johnson Journal: Proc Natl Acad Sci U S A Date: 2019-09-16 Impact factor: 11.205
Authors: Laura A N Peferoen; Wouter H Gerritsen; Marjolein Breur; Kimberley M D Ummenthum; Regina M B Peferoen-Baert; Paul van der Valk; Johannes M van Noort; Sandra Amor Journal: Acta Neuropathol Commun Date: 2015-12-22 Impact factor: 7.801
Authors: R P Gorter; E Nutma; M-C Jahrei; J C de Jonge; R A Quinlan; P van der Valk; J M van Noort; W Baron; S Amor Journal: Clin Exp Immunol Date: 2018-09-19 Impact factor: 4.330